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Regarding “Functional outcome after
thoracoabdominal aneurysm repair”
The authors are commended for their aim to look beyond
simple mortality statistics and assess long-term outcomes after
thoracoabdominal intervention.1 The assumption that such a large
intervention may impact long-term quality of life is intuitive, and
investigating the details of this impact will inform future practice.
We are, however, concerned about the conclusions being drawn
from the current study due to the nature of the respondents, and
the generalizability of this data to the preoperative thoracoabdomi-
nal population.
On the first point, it should be emphasized that in reviewing
the patients eligible for inclusion, the authors found that only
47% of their cohort (204 of 435) survived to be included in this
analysis, on average five years. Further to that, the response rate
of the survey was 67%, which diminished the number of patients
from whom this information is gathered to 134 people, or
30.8% of the original population. A conclusion stating that
“Permanent loss of functional capacity . . . occurs rarely in sur-
vivors of thoracobdominal aortic aneurysm (TAAA) repair” may
have been carefully worded, but is misleading in that the
majority of patients who underwent the procedure did notsurvive to contribute to the data presented, and those who did
may have, by definition, a higher functional capacity. The
interpretation is further challenged by the lack of baseline data
in the study population, which makes it difficult to ascertain if
the performance after five years of convalescence is actually a return
to the age-appropriate norm, or a deterioration in what was likely an
exceptional group of patients.
This leads to the second point, in which the generalizability of
these outcomes to the population of all TAAA is challenging
because of the large cohort who did not survive or were not able to
complete the questionnaire. If this small population of patients
who do relatively well could be predicted in advance of surgery,
then this quality of life data would be applicable. However, we feel
the selection bias present in the sample challenges the utility of the
data gathered. We believe the only way to truly determine the
effect that any form of intervention for thoracoabdominal aneu-
rysm has on the patients in whom it is performed is a protocolized
and prospective longitudinal study for all patients presenting with
thoracoabdominal disease.
Tara M. Mastracci, MD
Roy K. Greenberg, MD
The Cleveland Clinic Foundation
Cleveland, Ohio
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Reply
Drs Greenberg and Mastracci raise concerns about the gener-
alizability of our results given the stated mortality rate in our study,
the response rate obtained from our survey, and our lack of
available baseline quality of life (QOL) score. A suggestion is made
that a protocolized, prospective, longitudinal study would help us
more accurately determine the effect of an intervention for thora-
coabdominal aneurysm repair (TAA).
On the first point, our published 5-year mortality rate of 47%
is in line with other published large series for thoracoabdominal
aneurysm repair.1 Given that this is a long-term functional out-
come study in survivors of TAA repair, even a prospective study
would not allow us to improve on our ability to get more complete
data at the 5-year time point.
On the second point, surely a 100% response rate would be
desired. There is no definitive acceptable mail response rate (ie, free
from response bias); it can range from 30-70% depending on the
methodology being used (ie, established panel or randommailing,
etc). QualityMetric (Lincoln, RI) has typically had a 60-70% mail
response rate in its SF-36/SF-36v2 norming studies (personal
communication). Our response rate of 67% is comparable to this,
thus our cohort data accurately reflects the long term functional
outcomes of the group as a whole.
On the third point, we certainly agree that having a baseline
QOL score would be the optimal methodology; absent this the
QualityMetric norm-population, although controlled for age, is
obviously irrelevant to a population of TAA patients. An effort
was made to find a comparable group of patients, from both a
co-morbidity and age stand-point, to use as a control. We
believe that the comparison to the cardiovascular disease cohort
used provides the most accurate surrogate to baseline QOL
scores.
A recently published report by Zierer, et al2 on 25 survivors
of TAA, using the same SF36 tool at an average of 3 years, found
results remarkably consistent with our own. Outcome studies
after open TAA repair that paint a pessimistic picture3 after TAA
